These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34601503)

  • 41. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
    Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
    Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transfection of DHFR- and DHFR+ mammalian cells using methotrexate-resistant mutants of mouse dihydrofolate reductase.
    Thillet J; Pictet R
    FEBS Lett; 1990 Sep; 269(2):450-3. PubMed ID: 2401371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemistry of dihydrofolate reductase in methotrexate-sensitive and -resistant human cell lines by flow cytometry: a comparison with the cytochemical tetrazolium salt method.
    Nano R; Gerzeli G; Morandi C; Arisi C
    Acta Histochem; 1992; 93(1):290-7. PubMed ID: 1529671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulation of dihydrofolate reductase promoter activity by antimetabolic drugs.
    Eastman HB; Swick AG; Schmitt MC; Azizkhan JC
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8572-6. PubMed ID: 1833762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells.
    Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA
    Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate induces astrocyte apoptosis by disrupting folate metabolism in the mouse juvenile central nervous system.
    Shao Y; Tan B; Shi J; Zhou Q
    Toxicol Lett; 2019 Feb; 301():146-156. PubMed ID: 30502384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the coexisting multiple mechanisms of methotrexate resistance in mouse 3T6 R50 fibroblasts.
    Assaraf YG; Feder JN; Sharma RC; Wright JE; Rosowsky A; Shane B; Schimke RT
    J Biol Chem; 1992 Mar; 267(9):5776-84. PubMed ID: 1372892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
    Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Double-mutant dihydrofolate reductase gene transfection into bone marrow cells protects mice from chemotherapy].
    Gao HD; Lu P; Lu Y; Pang K; Xu HM; Wang SB; Chen JQ; Zhao SC
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):583-5. PubMed ID: 17236551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen
    DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
    Sastry KJ; Chan TS; Rodriguez LV
    Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular cloning and expression of the dihydrofolate reductase (DHFR) gene from adult buffalo fly (Haematobia irritans exigua): effects of antifolates.
    Elvin CM; Liyou NE; Pearson R; Kemp DH; Dixon NE
    Insect Mol Biol; 2003 Apr; 12(2):173-83. PubMed ID: 12653939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region.
    Ercikan-Abali EA; Banerjee D; Waltham MC; Skacel N; Scotto KW; Bertino JR
    Biochemistry; 1997 Oct; 36(40):12317-22. PubMed ID: 9315871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.
    Sowers R; Toguchida J; Qin J; Meyers PA; Healey JH; Huvos A; Banerjee D; Bertino JR; Gorlick R
    Mol Cancer Ther; 2003 Jun; 2(6):535-41. PubMed ID: 12813132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of a wild-type dihydrofolate reductase-encoding cDNA as a dominant selectable marker and induction of expression by methotrexate.
    Lo KM; Lynch CA; Gillies SD
    Gene; 1992 Nov; 121(2):365-9. PubMed ID: 1446834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced degradation of dihydrofolate reductase through inhibition of NAD kinase by nicotinamide analogs.
    Hsieh YC; Tedeschi P; Adebisi Lawal R; Banerjee D; Scotto K; Kerrigan JE; Lee KC; Johnson-Farley N; Bertino JR; Abali EE
    Mol Pharmacol; 2013 Feb; 83(2):339-53. PubMed ID: 23197646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolome Analysis Reveals Excessive Glycolysis via PI3K/AKT/mTOR and RAS/MAPK Signaling in Methotrexate-Resistant Primary CNS Lymphoma-Derived Cells.
    Takashima Y; Hayano A; Yamanaka R
    Clin Cancer Res; 2020 Jun; 26(11):2754-2766. PubMed ID: 32108030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo protection of activated Tyr22-dihydrofolate reductase gene-modified canine T lymphocytes from methotrexate.
    Gori JL; Beard BC; Williams NP; Ironside C; Swanson D; Scott McIvor R; Kiem HP
    J Gene Med; 2013; 15(6-7):233-41. PubMed ID: 23666780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.